Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Lin Y-C, Chang Y-H, Yang S-Y, Wu K-D, Chu T-S. Update of pathophysiology and management of diabetic kidney disease. J Formos Med Assoc. 2018;117:662–75. https://doi.org/10.1016/j.jfma.2018.02.007.
2. Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102:248–60. https://doi.org/10.1016/j.kint.2022.05.012.
3. Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacology. 2015;5:49–56.
4. Noubiap JJN, Naidoo J, Kengne AP. Diabetic nephropathy in Africa: A systematic review. World J Diabetes. 2015;6:759–73. https://doi.org/10.4239/wjd.v6.i5.759.
5. Djrolo F, Attolou VG, Avode DG, Houngbe F, Akpona S, Addra B, et al. Diabetic nephropathy: an epidemiological study based on proteinuria in a population of black African diabetics in Cotonou, Benin. Sante Montrouge Fr. 2001;11:105–9.